1709-P: Perceptions of Treatment Outcomes in People with Obesity and T2D—A Qualitative Study
Background: Treatments for obesity and T2D often combine lifestyle changes (diet, physical activity) and medication. Weight reduction is an expected outcome of obesity and some T2D treatments. Individuals’ perspectives on obesity treatments, attitudes towards reduced food intake via appetite changes...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 72; no. Supplement_1; p. 1 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
American Diabetes Association
20.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Treatments for obesity and T2D often combine lifestyle changes (diet, physical activity) and medication. Weight reduction is an expected outcome of obesity and some T2D treatments. Individuals’ perspectives on obesity treatments, attitudes towards reduced food intake via appetite changes, and treatment-related gastrointestinal adverse events (GI AEs) are not well characterized. The current study assessed individuals’ perceptions of obesity/T2D treatments that impact appetite, eating behaviors, and weight, and concerns about GI AEs.
Methods: This cross-sectional study involved semi-structured interviews with 45 US adults (obesity, n=15; overweight, n=10; T2D, n=20). Two creative tasks explored participants’ perceptions of obesity/T2D treatment outcomes: 1) participants discussed perspectives on hypothetical obesity/T2D treatments that reduced appetite, hunger, and cravings; 2) participants indicated their choice from two hypothetical obesity/T2D treatments, which varied by degree of GI AEs, appetite changes, and weight reduction. Interviews were audio recorded and transcribed for analysis.
Results: Most participants asked (28/35; 80%) perceived the hypothetical scenarios as a positive outcome of obesity/T2D treatment. Most (30/35; 86%) considered appetite reduction to be an important treatment benefit. Many also perceived fewer cravings (13/29; 45%) and lesser desire to eat (12/29; 41%) to be positive treatment outcomes. Participants associated treatment-related appetite changes with improvements in diet (10/33; 30%), emotional well-being (9/33; 27%), and daily activities (8/33; 24%). In the choice task, participants perceived appetite and weight reduction as positive treatment outcomes, irrespective of degree of GI AEs.
Conclusions: Findings demonstrate that participants value appetite changes and/or weight reduction as treatment priorities, and are willing to accept potential GI AEs for these treatment outcomes.
Disclosure
J.Poon: Employee; Eli Lilly and Company, Stock/Shareholder; Eli Lilly and Company. L.O'hara: Other Relationship; Lilly. H.Kendal: Other Relationship; Eli Lilly and Company. K.Sully: None. M.Guy: Employee; Adelphi Values, Other Relationship; Eli Lilly and Company. H.Bradley: Other Relationship; Eli Lilly and Company. C.Tolley: None. B.Mason: None. |
---|---|
AbstractList | Background: Treatments for obesity and T2D often combine lifestyle changes (diet, physical activity) and medication. Weight reduction is an expected outcome of obesity and some T2D treatments. Individuals' perspectives on obesity treatments, attitudes towards reduced food intake via appetite changes, and treatment-related gastrointestinal adverse events (GI AEs) are not well characterized. The current study assessed individuals' perceptions of obesity/T2D treatments that impact appetite, eating behaviors, and weight, and concerns about GI AEs. Methods: This cross-sectional study involved semi-structured interviews with 45 US adults (obesity, n=15; overweight, n=10; T2D, n=20). Two creative tasks explored participants' perceptions of obesity/T2D treatment outcomes: 1) participants discussed perspectives on hypothetical obesity/T2D treatments that reduced appetite, hunger, and cravings; 2) participants indicated their choice from two hypothetical obesity/T2D treatments, which varied by degree of GI AEs, appetite changes, and weight reduction. Interviews were audio recorded and transcribed for analysis. Results: Most participants asked (28/35; 80%) perceived the hypothetical scenarios as a positive outcome of obesity/T2D treatment. Most (30/35; 86%) considered appetite reduction to be an important treatment benefit. Many also perceived fewer cravings (13/29; 45%) and lesser desire to eat (12/29; 41%) to be positive treatment outcomes. Participants associated treatment-related appetite changes with improvements in diet (10/33; 30%), emotional well-being (9/33; 27%), and daily activities (8/33; 24%). In the choice task, participants perceived appetite and weight reduction as positive treatment outcomes, irrespective of degree of GI AEs. Conclusions: Findings demonstrate that participants value appetite changes and/or weight reduction as treatment priorities, and are willing to accept potential GI AEs for these treatment outcomes. Background: Treatments for obesity and T2D often combine lifestyle changes (diet, physical activity) and medication. Weight reduction is an expected outcome of obesity and some T2D treatments. Individuals’ perspectives on obesity treatments, attitudes towards reduced food intake via appetite changes, and treatment-related gastrointestinal adverse events (GI AEs) are not well characterized. The current study assessed individuals’ perceptions of obesity/T2D treatments that impact appetite, eating behaviors, and weight, and concerns about GI AEs. Methods: This cross-sectional study involved semi-structured interviews with 45 US adults (obesity, n=15; overweight, n=10; T2D, n=20). Two creative tasks explored participants’ perceptions of obesity/T2D treatment outcomes: 1) participants discussed perspectives on hypothetical obesity/T2D treatments that reduced appetite, hunger, and cravings; 2) participants indicated their choice from two hypothetical obesity/T2D treatments, which varied by degree of GI AEs, appetite changes, and weight reduction. Interviews were audio recorded and transcribed for analysis. Results: Most participants asked (28/35; 80%) perceived the hypothetical scenarios as a positive outcome of obesity/T2D treatment. Most (30/35; 86%) considered appetite reduction to be an important treatment benefit. Many also perceived fewer cravings (13/29; 45%) and lesser desire to eat (12/29; 41%) to be positive treatment outcomes. Participants associated treatment-related appetite changes with improvements in diet (10/33; 30%), emotional well-being (9/33; 27%), and daily activities (8/33; 24%). In the choice task, participants perceived appetite and weight reduction as positive treatment outcomes, irrespective of degree of GI AEs. Conclusions: Findings demonstrate that participants value appetite changes and/or weight reduction as treatment priorities, and are willing to accept potential GI AEs for these treatment outcomes. Disclosure J.Poon: Employee; Eli Lilly and Company, Stock/Shareholder; Eli Lilly and Company. L.O'hara: Other Relationship; Lilly. H.Kendal: Other Relationship; Eli Lilly and Company. K.Sully: None. M.Guy: Employee; Adelphi Values, Other Relationship; Eli Lilly and Company. H.Bradley: Other Relationship; Eli Lilly and Company. C.Tolley: None. B.Mason: None. |
Author | LING POON, JIAT TOLLEY, CHLOE BRADLEY, HELENA SULLY, KATE KENDAL, HELEN O'HARA, LOUISE MASON, BRAD GUY, MARGARET |
Author_xml | – sequence: 1 givenname: JIAT surname: LING POON fullname: LING POON, JIAT – sequence: 2 givenname: LOUISE surname: O'HARA fullname: O'HARA, LOUISE – sequence: 3 givenname: HELEN surname: KENDAL fullname: KENDAL, HELEN – sequence: 4 givenname: KATE surname: SULLY fullname: SULLY, KATE – sequence: 5 givenname: MARGARET surname: GUY fullname: GUY, MARGARET – sequence: 6 givenname: HELENA surname: BRADLEY fullname: BRADLEY, HELENA – sequence: 7 givenname: CHLOE surname: TOLLEY fullname: TOLLEY, CHLOE – sequence: 8 givenname: BRAD surname: MASON fullname: MASON, BRAD |
BookMark | eNotkMtKAzEYhYNUsK2ufIGASxnNbS5xV-oVCq04C1eGJJNgSjsZk4zSnQ_hE_okTqn8i7P4P86BbwJGrW8NAOcYXRFKy-tGEZrhEvFsdQTGmFOeUVK-jsAYIUyGDy9PwCTGNUKoGG4M3g70DVyZoE2XnG8j9BbWwci0NW2Cyz5pvzURunaAfLcx8Muld7hUJrq0g7JtYE1uf79_ZvC5lxuXZHKfBr6kvtmdgmMrN9Gc_ecU1Pd39fwxWywfnuazRaYLVmSNJDmrcoWZ1opzxBUjihppG6SozTHHqjSWFSQvpMaNkhVnipeVLJhFREs6BReH2i74j97EJNa-D-2wKEjFOM0rSouBujxQOvgYg7GiC24rw05gJPb-xN6f2BsRK_oH-jdkuw |
ContentType | Journal Article |
Copyright | Copyright American Diabetes Association Jun 2023 |
Copyright_xml | – notice: Copyright American Diabetes Association Jun 2023 |
DBID | AAYXX CITATION K9. NAPCQ |
DOI | 10.2337/db23-1709-P |
DatabaseName | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
ExternalDocumentID | 10_2337_db23_1709_P |
Genre | Conference Proceeding |
GroupedDBID | --- .55 .XZ 08P 0R~ 18M 29F 2WC 354 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAQQT AAWTL AAYEP AAYXX ABOCM ACGFO ACGOD ACPRK ADBBV AEGXH AENEX AERZD AFHIN AHMBA AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BES BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EMOBN EX3 F5P FRP GX1 HZ~ IAO IEA IHR INH INR IOF IPO K2M KQ8 L7B M5~ O5R O5S O9- OHH OK1 OVD P2P PCD Q2X RHF RHI RPM SJN SV3 TDI TEORI TR2 VVN W8F WH7 WOQ WOW X7M YFH YHG YOC ZY1 ~KM K9. NAPCQ |
ID | FETCH-LOGICAL-c646-da25485b14ccb9909b42b3eafd0b3f5191b7ef46256ac1dba894b978a64f02ca3 |
ISSN | 0012-1797 |
IngestDate | Thu Oct 10 16:38:19 EDT 2024 Fri Aug 23 01:06:28 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Supplement_1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c646-da25485b14ccb9909b42b3eafd0b3f5191b7ef46256ac1dba894b978a64f02ca3 |
PQID | 2849358336 |
PQPubID | 34443 |
ParticipantIDs | proquest_journals_2849358336 crossref_primary_10_2337_db23_1709_P |
PublicationCentury | 2000 |
PublicationDate | 2023-06-20 |
PublicationDateYYYYMMDD | 2023-06-20 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationYear | 2023 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
SSID | ssj0006060 |
Score | 2.473469 |
Snippet | Background: Treatments for obesity and T2D often combine lifestyle changes (diet, physical activity) and medication. Weight reduction is an expected outcome of... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 1 |
SubjectTerms | Appetite Appetite loss Body weight Clinical outcomes Diet Food intake Obesity Overweight Perceptions Physical activity |
Title | 1709-P: Perceptions of Treatment Outcomes in People with Obesity and T2D—A Qualitative Study |
URI | https://www.proquest.com/docview/2849358336 |
Volume | 72 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PT9swFLcYSNMuaH81NkA-cEOB2HHjhltEg1oItBqpxC6LYjuRdinTKJed9iH2Cfkke89OUoN6YLtEVVo7kd-v9vvze-8RcqAqoQFGSVDpRgYiabAboACbR2mwn3WdMFft8yoez8X5zeDGi5hidslSHelfa_NK_keqcA_kilmy_yDZflK4AZ9BvnAFCcP1WTJmMkyCGRr1sxU_BdW_oqePT--X8GTLuoIfIVvcuV7bhgA2dlDwUcd5EOmhq6rh6oFf98VnW_115Llqnzbx8ZwKOfrAZtOp5RCcT9KeiY3cmnH6JbXugOl8ct0nQlxkV6M0tydhlmerANE8z7_a3SgtMt9FwbFdRMBDf9tlHOugSn_bldyDl21hav2hJVu3sfPIlgYwimNBVVzb1fnVxeyfHGs92RDMHBxe4uASB5ezF2SLy2SAFNDR5KI_ucGYcylL7eu6fE4cfOw9-bEG8_gAt1pJ8Zpst-YETR023pCNevGWvLxsCRPvyDc32Qn1AEJvG9oDhHYAod8X1AGEIkBoCxAKAKEAkIfff1LqQYNaaLwnxVlWnI6DtqVGoGMRB6biYKEOFBNaK9BDEiW4iuqqMaGKGlDmmZJ1I8AmjivNjKqGiVCJHFaxaEKuq-gD2VzcLuqPhMaGMaMNfCMiEdZGgd5XazmMDKhdWrIdctCtUvnDFU4p10hih-x2K1i2_6y7ElQmDM9HUfzpebN8Jq9WuNslm8uf9_UeKItLtW8l_BfZwWLm |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=1709-P%3A+Perceptions+of+Treatment+Outcomes+in+People+with+Obesity+and+T2D%E2%80%94A+Qualitative+Study&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=LING+POON%2C+JIAT&rft.au=O%27HARA%2C+LOUISE&rft.au=KENDAL%2C+HELEN&rft.au=SULLY%2C+KATE&rft.date=2023-06-20&rft.issn=0012-1797&rft.volume=72&rft.issue=Supplement_1&rft_id=info:doi/10.2337%2Fdb23-1709-P&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_db23_1709_P |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |